Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by treatment area as follows:

- oncology (36.8%);

- respiratory diseases (22.9%);

- cardiovascular, renal and metabolic diseases (18.6%);

- other (21.7%): inflammatory and autoimmune diseases, neurological diseases, gastrointestinal and infectious diseases.

Net sales are distributed geographically as follows: the United Kingdom (2%), Continental Europe (16.5%), Americas (38.3%) and Africa/Asia/Australia (43.2%).

Number of employees : 70 600 people.
Sales per Business
20182019Delta
GBP (in Million)%GBP (in Million)%
Oncology4,52127.3%6,79435.5% +50.28%
Cardiovascular, Renal & Metabolism5,03230.4%5,41328.3% +7.57%
Respiratory3,68322.2%4,22622.1% +14.74%
Other Diseases2,55015.4%2,03910.7% -20.04%
Externalisation Revenue780.714.7%641.983.4% -17.77%
Sales per region
2019
GBP (in Million)%
United States6,30833%
China3,81520%
Japan1,97710.3%
United Kingdom1,4287.5%
Other Asia, Africa and Australasia1,1125.8%
Other Continental Europe1,0125.3%
Sweden653.743.4%
Other Americas638.063.3%
Germany551.842.9%
France453.072.4%
Managers and Directors
NameAgeSinceTitle
Pascal Soriot602012Chief Executive Officer & Executive Director
Leif Johansson692012Non-Executive Chairman
Pam Cheng492015Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer682013Chief Financial Officer & Executive Director
Menelas N. Pangalos, Dr.-2019EVP-Biopharmaceuticals Research & Development
José Baselga, Dr.61-Executive VP-Oncology Research & Development
Henry D. Cremisi, Dr.--Medical Director
Marcus Wallenberg641999Independent Non-Executive Director
Graham Chipchase572019Senior Independent Non-Executive Director
Geneviéve B. Berger, Dr.652012Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,312,668,724 1,256,822,435 95.7% 0 0.0% 95.7%
Shareholders
NameEquities%
Investor AB (Investment Company) 51,587,810 3.93%
BlackRock Investment Management (UK) Ltd. 42,170,900 3.21%
Capital Research & Management Co. (World Investors) 41,526,368 3.16%
Wellington Management Co. LLP 38,725,550 2.95%
The Vanguard Group, Inc. 37,200,514 2.83%
Norges Bank Investment Management 31,680,000 2.41%
BlackRock Fund Advisors 24,452,643 1.86%
BlackRock Advisors (UK) Ltd. 16,769,205 1.28%
Fidelity Management & Research Co. LLC 15,972,842 1.22%
SSgA Funds Management, Inc. 13,880,589 1.06%
Holdings
NameEquities%Valuation
AstraZeneca Pharma India Limited (506820) 18,750,00075.0%1,185,919,688 USD
Viela Bio, Inc. (VIE) 14,650,33426.7%526,972,514 USD
ADC Therapeutics SA (ADCT) 3,811,2154.97%121,996,992 USD
Innate Pharma (IPH) 7,485,5009.48%31,708,054 USD
Circassia Group Plc (CIR) 71,081,21717.9%27,400,388 USD
PhaseBio Pharmaceuticals, Inc. (PHAS) 3,004,55410.2%10,095,301 USD
Entasis Therapeutics Holdings Inc. (ETTX) 2,164,8556.10%5,347,192 USD
Markets and indexes
-
- Main Market
- OMX Stockholm 30 / FTSE 100, FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, NASDAQ OMX Nordic 120, OMX Nordic 40, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  AZN:LN
- Reuters Code :  AZN.L
- Datastream Code :  AZN
Company contact information
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA Cambridge, Cambridgeshire


Phone : +44 (0)20 3749 5000
Fax : +44 (0)20 7604 8151
web site : http://www.astrazeneca.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of AstraZeneca PLC
Sector Pharmaceuticals - NEC